Pulmonary Arteriovenous Malformations: Addressing the Disease, Economic Burden, and Best Treatment Options

Pulmonary Arteriovenous Malformations: Addressing the Disease, Economic Burden, and Best Treatment Options

On-Demand Webcast
FACULTY

Ripal Gandhi, MD, FSVM, FSIR
Associate Clinical Professor
Florida International University,
Herbert Wertheim College of Medicine
Miami Cardiac & Vascular Institute
Miami, Florida

Sanjeeva Kalva, MD, MBBS
Chief, Division of Interventional Radiology
Massachusetts General Hospital
Boston, Massachusetts

Miles Conrad, MD, MPH
Clinical Professor, Department of Radiology
University of California, San Francisco
San Francisco, California

Clifford Weiss, MD
Interventional Radiology
The Johns Hopkins University School of Medicine
Baltimore, Maryland

PROVIDER STATEMENT

 
Provided by North American Center for Continuing Medical Education, LLC, an HMP Company.

For questions regarding this educational activity, please call 609-371-1137 or email info@naccme.com.

INTENDED LEARNERS

This activity is designed for interventional radiologists, vascular surgeons, interventional cardiologists, interventional neuroradiologists, cardiothoracic surgeons, clinical cardiologists, clinical radiologists, neurologists, internists, nurses and others involved in the treatment of cardiovascular disease.

Learning Objectives

After participating in this activity, participants should be better able to:

  • Identify the clinical features that contribute and recognize the diagnosis approach for HHT. 
  • Understand the risk of recanalization and how to prevent it during intervention.  
  • Identify the best treatment options for Pulmonary AVMs.
CLAIMING CREDIT

To be eligible for credit, participants must view the webinar, complete the online activity, the post-test assessment, and the evaluation by March 31, 2022. Upon completing the activity, there will be instructions on how to print a certificate or other documentation of credit.

Release Date: February 28, 2019
Expiration Date: March 31, 2022
Estimated time to complete: 1 hour

There is no fee associated with this activity.

COMMERCIAL SUPPORT

NACCME would like to thank the following company who has supported the "Pulmonary Arteriovenous Malformations: Addressing the Disease, Economic Burden, and Best Treatment Options" through an educational grant: Medtronic

CONTINUING EDUCATION

  In support of improving patient care, NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIANS

NACCME designates this internet enduring activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSING

This continuing nursing education activity awards 1.0 contact hour.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hour.

PHYSICIAN ASSISTANTS

NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1.00 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 credit. PAs should only claim credit commensurate with the extent of their participation.

VASCULAR & INTERVENTIONAL RADIOGRAPHERS

Pulmonary Arteriovenous Malformations: Addressing the Disease, Economic Burden, and Best Treatment Options, taking place on DAY, DATE from TIME has been approved for 1.00 A+ ARRT CE credits by the Association for Vascular and Interventional Radiographers (AVIR). The AVIR is an ARRT Recognized Continuing Education Evaluating Mechanism, (RCEEM).

USE OF PROPRIETARY NAMES

This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.

UNAPPROVED AND/OR INVESTIGATIONAL USES OF DRUGS AND DEVICES

This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of NACCME.

DISCLAIMERS

The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.

Neither NACCME nor any of its subsidiaries or affiliates is affiliated with, or formally endorsed by a medical society.

The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME or HMP. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

NACCME, LLC is an independent provider of continuing medical education. NACCME, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.

In accordance with our disclosure policies, NACCME is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real conflicts of interest between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME.

Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:

  1. Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and;
  2. any investigational, off-label, or non-FDA approved content or discussion

NACCME has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.

Education has been independently peer-reviewed to validate content, mitigate identified conflicts of interest, and ensure:

  1. All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
  2. All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
  3. Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.

FACULTY

The faculty has reported the following:

Dr. Conrad: Consultant—Medtronic

Dr. Gandhi: Consultant—BD, Cordis/Cardinal Health, Medtronic, Sirtex Medical, Trisalus Life Sciences; Speakers' Bureau—BD, Medtronic, Sirtex Medical; Proctor—Sirtex Medical

Dr. Kalva: Consultant—Boston Scientific, Medtronic, Okami, Penumbra, Sirtex; Stock—Althea Health, Moderna; Royalty—Elsevier, Springer

Dr. Weiss: Consultant—Boston Scientific, Medtronic; Grant Support—Boston Scientific, Medtronic, Siemens Healthcare

CLINICAL REVIEWER

Adam Geronemus, MD
Miami Cardiac & Vascular Institute
Miami, Florida

Dr. Geronemus has disclosed no relevant financial relationship with any ineligible company (commercial interest).

PLANNING COMMITTEE

Susie Seaman, NP, MSN, CWOCN (nurse planner)
Susie Seaman Wound Care Consulting
San Diego, CA

Ms. Seaman has disclosed no relevant financial relationship with any ineligible company (commercial interest).

NACCME planners and staff include Samantha Conforti, MaryEllen Fama, Randy Robbin, Greaton Sellers, Margie Stefan, and Colleen Waters. 

No NACCME planner or staff has disclosed a relevant financial relationship with any ineligible company (commercial interest).

ADA STATEMENT

North American Center for Continuing Medical Education (NACCME) complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.

PRIVACY POLICY

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint providers. NACCME and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2021 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.